Literature DB >> 15617368

Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.

Michael L Johnson1, Kenneth Pietz, David S Battleman, Rebecca J Beyth.   

Abstract

OBJECTIVES: To estimate the prevalence of concurrent hypertension and dyslipidemia among a general veteran population and separately among patients with diabetes mellitus, and to compare the prevalence of cardiovascular disease among groups with isolated versus concurrent hypertension and dyslipidemia. STUDY
DESIGN: Retrospective cohort study. PATIENTS AND METHODS: This study was conducted in 6 medical centers of the Department of Veterans Affairs and included 371221 patients seen for any reason from October 1, 1998, to September 30, 2001. The proportion of patients with isolated or concurrent hypertension and dyslipidemia was estimated based on diagnostic, pharmacy, laboratory, and vital sign information, and the age-adjusted proportions of individuals with cardiovascular disease were compared between groups.
RESULTS: We found that 57.8% of all patients had hypertension or dyslipidemia; 30.7% had both. Sixteen percent of all patients had diabetes mellitus, and 66.3% of these patients had concomitant hypertension and dyslipidemia. The prevalence of coronary artery disease was often more than doubled among patients with concomitant conditions compared with patients with either condition alone. The prevalence of stroke and peripheral arterial disease similarly increased among patients with both conditions. The prevalence of these cardiovascular diseases was highest among patients with diabetes mellitus.
CONCLUSION: The prevalence of cardiovascular disease was high among this population of older, predominately male US veterans.

Entities:  

Mesh:

Year:  2004        PMID: 15617368

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  48 in total

1.  Patterns of antihypertensive therapy among patients with diabetes.

Authors:  Michael L Johnson; Hardeep Singh
Journal:  J Gen Intern Med       Date:  2005-09       Impact factor: 5.128

2.  Prevalence and treatment of isolated and concurrent hypertension and hypercholesterolaemia in the United Kingdom.

Authors:  Thomas M MacDonald; Steven V Morant
Journal:  Br J Clin Pharmacol       Date:  2008-02-14       Impact factor: 4.335

3.  Myocardial infarction risk among patients with fractures receiving bisphosphonates.

Authors:  Cory B Pittman; Lisa A Davis; Angelique L Zeringue; Liron Caplan; Kent R Wehmeier; Jeffrey F Scherrer; Hong Xian; Francesca E Cunningham; Jay R McDonald; Alexis Arnold; Seth A Eisen
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

Review 4.  Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2013-10-21

Review 5.  Chronotherapy for Hypertension.

Authors:  N P Bowles; S S Thosar; M X Herzig; S A Shea
Journal:  Curr Hypertens Rep       Date:  2018-09-28       Impact factor: 5.369

6.  The Effect of Curcumin in Improving Lipid Profile in Patients with Cardiovascular Risk Factors: A Systematic Review of Clinical Trials.

Authors:  Sahar Rafiee; Mohammad Bagherniya; Gholamreza Askari; Thozhukat Sathyapalan; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management.

Authors:  R Preston Mason
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Longitudinal Cognitive Trajectories of Women Veterans from the Women's Health Initiative Memory Study.

Authors:  Claudia B Padula; Julie C Weitlauf; Allyson C Rosen; Gayle Reiber; Barbara B Cochrane; Michelle J Naughton; Wenjun Li; Michelle Rissling; Kristine Yaffe; Julie R Hunt; Marcia L Stefanick; Mary K Goldstein; Mark A Espeland
Journal:  Gerontologist       Date:  2015-11-27

Review 9.  Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction.

Authors:  William H Frishman; Linda S Henderson; Mary Ann Lukas
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Patient adherence and preference considerations in managing cardiovascular risk: focus on single pill and amlodipine/atorvastatin fixed combination.

Authors:  Farhan Aslam; Attiya Haque; Veronica Lee; Joanne Foody
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.